Clinical Trials Browser

Phase 1/2 × Stomach Neoplasms × Receptor Protein-Tyrosine Kinases × Clear all

NCT00681252 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

NCT00681577 2009-11-19

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms